$2.27T
Total marketcap
$126.96B
Total volume
BTC 49.87%     ETH 15.71%
Dominance

Venus Concept VERO Stock

0.68 USD {{ price }} -3.061513% {{change_pct}}%
Exchange
NasdaqCM
Market Cap
4.31M USD
LOW - HIGH [24H]
0.63 - 0.69 USD
VOLUME [24H]
18.18K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-6.84 USD

Venus Concept Price Chart

Venus Concept VERO Financial and Trading Overview

Venus Concept stock price 0.68 USD
Previous Close 2.39 USD
Open 2.31 USD
Bid 0 USD x 3000
Ask 0 USD x 800
Day's Range 2.3 - 2.52 USD
52 Week Range 2.06 - 11.7 USD
Volume 11.63K USD
Avg. Volume 31.37K USD
Market Cap 12.66M USD
Beta (5Y Monthly) 1.010207
PE Ratio (TTM) N/A
EPS (TTM) -6.84 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 13 USD

VERO Valuation Measures

Enterprise Value 90.63M USD
Trailing P/E N/A
Forward P/E -0.9115384
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.1352071
Price/Book (mrq) N/A
Enterprise Value/Revenue 0.968
Enterprise Value/EBITDA -2.902

Trading Information

Venus Concept Stock Price History

Beta (5Y Monthly) 1.010207
52-Week Change -69.61%
S&P500 52-Week Change 20.43%
52 Week High 11.7 USD
52 Week Low 2.06 USD
50-Day Moving Average 2.72 USD
200-Day Moving Average 4.16 USD

VERO Share Statistics

Avg. Volume (3 month) 31.37K USD
Avg. Daily Volume (10-Days) 13.07K USD
Shares Outstanding 5.34M
Float 3.32M
Short Ratio 0.9
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short 57.64K
Short % of Float 2.05%
Short % of Shares Outstanding 1.08%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:15

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -47.78%
Operating Margin (ttm) -38.019%
Gross Margin 66.12%
EBITDA Margin -33.35%

Management Effectiveness

Return on Assets (ttm) -17.29%
Return on Equity (ttm) -268.34%

Income Statement

Revenue (ttm) 93.62M USD
Revenue Per Share (ttm) 20.2 USD
Quarterly Revenue Growth (yoy) -22.19%
Gross Profit (ttm) N/A
EBITDA -31226000 USD
Net Income Avi to Common (ttm) -44738000 USD
Diluted EPS (ttm) -9.77
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 6.41M USD
Total Cash Per Share (mrq) 1.18 USD
Total Debt (mrq) 83.43M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 2.147
Book Value Per Share (mrq) -0.164

Cash Flow Statement

Operating Cash Flow (ttm) -20444000 USD
Levered Free Cash Flow (ttm) -11481125 USD

Profile of Venus Concept

Country United States
State ON
City Toronto
Address 235 Yorkland Boulevard
ZIP M2J 4Y8
Phone 877-848-8430
Website https://www.venusconcept.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 384

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Q&A For Venus Concept Stock

What is a current VERO stock price?

Venus Concept VERO stock price today per share is 0.68 USD.

How to purchase Venus Concept stock?

You can buy VERO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Venus Concept?

The stock symbol or ticker of Venus Concept is VERO.

Which industry does the Venus Concept company belong to?

The Venus Concept industry is Medical Devices.

How many shares does Venus Concept have in circulation?

The max supply of Venus Concept shares is 6.36M.

What is Venus Concept Price to Earnings Ratio (PE Ratio)?

Venus Concept PE Ratio is now.

What was Venus Concept earnings per share over the trailing 12 months (TTM)?

Venus Concept EPS is -6.84 USD over the trailing 12 months.

Which sector does the Venus Concept company belong to?

The Venus Concept sector is Healthcare.

Venus Concept VERO included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16175.09 USD
-1.62
3.94B USD 16125.33 USD 16341.46 USD 3.94B USD
NASDAQ Global Market Composite NQGM 2160.36 USD
-2.45
2147.48 USD 2200.33 USD
NASDAQ HealthCare IXHC 958.68 USD
-2.07
954.08 USD 972.42 USD